The FDA gave the OK last week for Pfizer's blood thinner Fragmin to be used in children — but Fragmin is not new, it's been on the market for adults since 1994.

Why it matters: This is another case of an older drug getting broader approval with limited evidence.

Between the lines: Fragmin is a relatively small medication for Pfizer, generating $293 million in sales in 2018, down from when sales were about $382 million in 2011. But getting an expanded approval will immediately create a return for Pfizer because the drug is still the same product — now with a bigger population to treat.

Go deeper: "Almost half of all new drug approvals in 2018 relied on one clinical trial," Zachary Brennan of RAPS Regulatory Focus reports.

Go deeper

Updated 20 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 1:30 p.m. ET: 32,919,487 — Total deaths: 995,352 — Total recoveries: 22,770,166Map.
  2. U.S.: Total confirmed cases as of 1:30 p.m. ET: 7,089,611 — Total deaths: 204,566 — Total recoveries: 2,750,459 — Total tests: 100,492,536Map.
  3. States: New York daily cases top 1,000 for first time since June — U.S. reports over 55,000 new coronavirus cases.
  4. Health: The long-term pain of the mental health pandemicFewer than 10% of Americans have coronavirus antibodies.
  5. Business: Millions start new businesses in time of coronavirus.
  6. Education: Summer college enrollment offers a glimpse of COVID-19's effect.

Biden on Supreme Court fight: "This is about whether or not the ACA will exist"

Joe Biden made health care the overwhelming focus of his remarks from Wilmington, Delaware, on Sunday, stressing that the Senate confirmation battle over Judge Amy Coney Barrett's nomination to the Supreme Court is about preserving the Affordable Care Act in the midst of a pandemic.

Why it matters: Democrats are aggressively pushing the message that Barrett, who has previously criticized Chief Justice John Roberts for his 2012 ruling salvaging the ACA, will seek to invalidate the law when the Supreme Court hears a Trump administration-backed lawsuit against it on Nov. 10.

McMaster: Trump's peaceful transition comments are a "gift to our adversaries"

President Trump's refusal to commit to a peaceful transfer of power if he loses November's presidential election is a "gift to our adversaries," Trump's former national security adviser H.R. McMaster said Sunday.

The big picture: McMaster, a retired three-star general, said that the American people must understand that the military will have "no role" in a presidential transition and that it's "irresponsible" to even talk about it as a possibility.